Meta-Analysis of the Efficacy of Ebastine 20 mg Compared to Loratadine 10 mg and Placebo in the Symptomatic Treatment of Seasonal Allergic Rhinitis

No abstract is available for this paper.

• Publication year

  2005

• Venue

  International Archives of Allergy and Immunology

• Publication date

  2005-10-11

• Fields of study

  Medicine

• Identifiers
  DOI 10.1159/000088869PMID 16224195
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A randomized, double-blind, placebo-controlled study comparing the efficacy and safety of ebastine (20 mg and 10 mg) to loratadine 10 mg once daily in the treatment of seasonal allergic rhinitis.

  2004cited by this paper
• Efficacy and Safety of Ebastine 20 mg Compared to Loratadine 10 mg Once Daily in the Treatment of Seasonal Allergic Rhinitis: A Randomized, Double-Blind, Placebo-Controlled Study

  2004cited by this paper
• Efficacy of ebastine in the control of nasal congestion associated with allergic rhinitis.

  2003influential reference
• Efficacy of ebastine, cetirizine, and loratadine in histamine cutaneous challenges.

  2002cited by this paper
• A double-blind, randomized, single-dose, crossover comparison of levocetirizine with ebastine, fexofenadine, loratadine, mizolastine, and placebo: suppression of histamine-induced wheal-and-flare response during 24 hours in healthy male subjects.

  2002cited by this paper
• Ebastine: an update of its use in allergic disorders.

  2000cited by this paper
• Applied Mixed Models in Medicine

  2000cited by this paper
• Comparison of once-daily ebastine 20 mg, ebastine 10 mg, loratadine 10 mg, and placebo in the treatment of seasonal allergic rhinitis. The Ebastine Study Group.

  2000cited by this paper
• A 12‐week, placebo‐controlled study of the efficacy and safety of ebastine, 10 and 20 mg once daily, in the treatment of perennial allergic rhinitis

  1999cited by this paper
• A double‐blind, single‐dose, crossover comparison of cetirizine, ebastine, epinastine, fexofenadine, terfenadine, and loratadine versus placebo: suppression of histamine‐induced wheal and flare response for 24 h in healthy male subjects

  1999cited by this paper
• Efficacy and tolerability comparison of ebastine 10 and 20mg with loratadine 10mg: a double-blind, randomised study in patients with perennial allergic rhinitis.

  1998cited by this paper
• Efficacy and Tolerability Comparison of Ebastine 10 and 20mg with Loratadine 10mg

  1998cited by this paper
• Comparison of ebastine to cetirizine in seasonal allergic rhinitis in adults.

  1996cited by this paper
• Loratadine. A reappraisal of its pharmacological properties and therapeutic use in allergic disorders.

  1994cited by this paper
• Meta-Analysis, Decision Analysis, and Cost-Effectiveness Analysis: Methods for Quantitative Synthesis in Medicine

  1994cited by this paper
• The statistical basis of meta-analysis.

  1993cited by this paper
• Controversies in meta-analysis: the case of the trials of serum cholesterol reduction

  1993cited by this paper
• Review papers : The statistical basis of meta-analysis

  1993cited by this paper
• A general parametric approach to the meta-analysis of randomized clinical trials.

  1991cited by this paper
• Efficacy and Tolerability of Ebastine at Two Dose Levels in the Treatment of Seasonal Allergic Rhinitis

  1989cited by this paper
• Considerations for the meta-analysis of randomized clinical trials. Summary of a panel discussion.

  1989cited by this paper

• Efficacy of warm needling in patients with persistent allergic rhinitis: a multicenter randomized controlled trial

  2025cites this paper
• Efficacy and safety of ebastine 10 mg and phenylephrine 10 mg fixed-dose combination in Indian patients with allergic rhinitis: A phase 4 multicentre study

  2024cites this paper
• Greens Appraisal of Validated Stability Indicating RP-HPLC Method and Forced Degradation Study for Quantification of Ebastine in Wastewater and Dosage Form.

  2023cites this paper
• Ebastine in the treatment of allergic rhinitis and urticaria: 30 years of clinical studies and real-world experience.

  2020cites this paper
• Pathophysiology of Allergic Rhinitis

  2019cites this paper
• Medical Treatment of Allergic Rhinitis

  2019cites this paper
• Curative effects of shikonin on allergic rhinitis in rats and the related mechanism

  2017cites this paper
• Steroidal and Nonsteroidal Anti-inflammatory Agents for Ocular Use

  2016cites this paper
• Antihistamines for the Treatment of Allergic Rhino-conjunctivitis

  2016cites this paper
• Symptomatische Therapie der allergischen Rhinitis unter besonderer Berücksichtigung nicht-pharmakologischer Behandlungsformen

  2013cites this paper
• The effectiveness of modern antihistamines for treatment of allergic rhinitis - an IPD meta-analysis of 140,853 patients.

  2013cites this paper
• Improving SAR symptoms with levocetirizine: evaluating active and placebo effects in pollen challenge vs. natural exposure studies

  2011cites this paper
• Effect of bilastine upon the ocular symptoms of allergic rhinoconjunctivitis.

  2011cites this paper
• Subcutaneous immunotherapy and pharmacotherapy in seasonal allergic rhinitis: a comparison based on meta-analyses.

  2011cites this paper
• Антигистаминные лекарственные средства: эффективность и безопасность применения в педиатрической практике

  2010cites this paper
• Optimizing Drug Therapy by Analogues

  2010cites this paper
• Pharmacotherapy of Allergic Rhinitis

  2010cites this paper
• Clinical utility and patient adherence with ebastine for allergic rhinitis

  2010cites this paper
• Estudio multicéntrico de satisfacción con ebastina de disolución rápida 20 mg/día en pacientes mexicanos con rinitis alérgica

  2009cites this paper
• Allergic conjunctivitis and H1 antihistamines.

  2009cites this paper
• Assessment of patient satisfaction with ebastine fast ‑ dissolving tablets in patients suffering from allergic rhinitis

  2009cites this paper
• Ebastine in the light of CONGA recommendations for the development of third-generation antihistamines

  2009cites this paper
• Ebastine fast-dissolving tablets versus regular tablets: acceptability and preference in patients with allergic rhinitis

  2008cites this paper
• The diagnosis and management of rhinitis: an updated practice parameter.

  2008cites this paper
• Ebastine in allergic rhinitis and chronic idiopathic urticaria

  2008cites this paper
• Allergic rhinitis: continuous or on demand antihistamine therapy?

  2007cites this paper
• Comparison of inhibition of cutaneous histamine reaction of ebastine fast-dissolving tablet (20 mg) versus desloratadine capsule (5 mg): a randomized, double-blind, double-dummy, placebo-controlled, three-period crossover study in healthy, nonatopic adults.

  2007cites this paper
• A Comparison of Ebastine 10mg Fast-Dissolving Tablet with Oral Desloratadine and Placebo in Inhibiting the Cutaneous Reaction to Histamine in Healthy Adults

  2007cites this paper
• [New generation antihistamines as monotherapy or in combination. What is the relevance for daily clinical routine for allergic rhinoconjunctivitis].

  2007cites this paper
• [Antihistamines in allergic rhinitis].

  2007cites this paper
• Mono- oder Kombinationstherapie mit einem Antihistaminikum

  2007cites this paper